Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It...
67 KB (6,296 words) - 21:21, 18 October 2024
possible therapeutic importance of memantine for treating neurodegenerative disorders was discovered. From 1989 memantine has been recognized to be an uncompetitive...
107 KB (12,058 words) - 11:59, 2 November 2024
Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the...
5 KB (185 words) - 16:10, 2 May 2024
cytoplasm). Amantadine is an adamantane derivative and is related to memantine and rimantadine. Amantadine was first used for the treatment of influenza...
62 KB (6,117 words) - 07:05, 16 November 2024
anxiolytic drug of the adamantane family that is related to amantadine and memantine. Medically, it is approved in Russia for the treatment of neurasthenia...
32 KB (3,257 words) - 02:04, 8 October 2024
National; (UK), Care Excellence (2019-12-27). Cholinesterase inhibitors and memantine for dementia. Retrieved 2019-12-27. {{cite book}}: |website= ignored (help)...
13 KB (1,107 words) - 04:21, 2 November 2024
and memantine, an NMDA receptor antagonist. The acetylcholinesterase inhibitors are intended for those with mild to severe AD, whereas memantine is intended...
186 KB (19,745 words) - 21:38, 13 November 2024
overall kinetics, of memantine could be the underlying reason for the clinical tolerance. As an uncompetitive antagonist, memantine should bring NMDA levels...
26 KB (3,020 words) - 11:51, 16 January 2024
Nitromemantine (developmental code name YQW-36) is a derivative of memantine developed in 2006 for the treatment of Alzheimer's disease. It has been shown...
4 KB (341 words) - 22:44, 29 January 2023
N06DA05 Ipidacrine N06DA52 Donepezil and memantine N06DA53 Donepezil, memantine and Ginkgo folium N06DX01 Memantine N06DX02 Ginkgo folium N06DX03 Aducanumab...
4 KB (441 words) - 21:47, 27 June 2024
analogue of gludantan, N-3,5-dimethylgludantan, is an inactive metabolite of memantine. Gludantan was developed in the Soviet Union and was first described by...
5 KB (290 words) - 07:50, 2 November 2024
Neramexane: a memantine analogue with nootropic, antidepressant properties. Also a nicotinic acetylcholine antagonist. Nitromemantine: a novel memantine derivative...
38 KB (4,196 words) - 12:46, 14 July 2024
drugs with variable success include gabapentin and, recently,[when?] memantine. Successful surgery options include superior oblique tenectomy accompanied...
5 KB (475 words) - 16:57, 10 November 2023
Arylcyclo‐ hexylamines Adamantanes Amantadine Memantine Rimantadine Diarylethylamines Diphenidine Ephenidine Fluorolintane Methoxphenidine Morphinans...
94 KB (9,773 words) - 02:55, 11 November 2024
donepezil, memantine, MPH, and modafinil. In the drug trials, participants reported the following adverse reactions to use of donepezil, memantine, MPH, modafinil...
27 KB (2,531 words) - 07:12, 11 November 2024
(laudolissin) Levacetylmethadol Levomethadone Malouetine ME-18-MC Mecamylamine Memantine Methadone Methorphan (racemethorphan) Methyllycaconitine Metocurine Mivacurium...
103 KB (10,986 words) - 06:41, 16 September 2024
(October 2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression...
50 KB (4,580 words) - 19:43, 21 November 2024
Lanicemine Levomethadone Levomethorphan Levomilnacipran Levorphanol Loperamide Memantine Methadone Methorphan Methoxetamine Methoxphenidine Milnacipran Morphanol...
123 KB (12,065 words) - 18:13, 15 November 2024
concentrations of agonist better than lower concentrations of agonist". Memantine, used in the treatment of Alzheimer's disease, is an uncompetitive antagonist...
33 KB (3,845 words) - 01:47, 19 August 2024
v t e Stimulants Adamantanes Adapromine Amantadine Bromantane Memantine Rimantadine Adenosine antagonists 8-Chlorotheophylline 8-Cyclopentyltheophylline...
156 KB (15,400 words) - 03:45, 20 November 2024
drugs found to be effective against nystagmus in some patients include memantine, levetiracetam, 3,4-diaminopyridine (available in the US to eligible patients...
37 KB (4,090 words) - 12:43, 1 November 2024
Arylcyclo‐ hexylamines Adamantanes Amantadine Memantine Rimantadine Diarylethylamines Diphenidine Ephenidine Fluorolintane Methoxphenidine Morphinans...
60 KB (5,263 words) - 07:26, 25 October 2024
v t e Stimulants Adamantanes Adapromine Amantadine Bromantane Memantine Rimantadine Adenosine antagonists 8-Chlorotheophylline 8-Cyclopentyltheophylline...
54 KB (5,329 words) - 05:19, 17 November 2024
Ifenprodil Igmesine (JO-1784) IPAB Ketamine L-687384 MDMA (midomafetamine) Memantine Methamphetamine Methoxetamine Methylphenidate Nepinalone Neuropeptide...
142 KB (15,101 words) - 17:03, 18 November 2024
Agonists Adamantanes: Amantadine Memantine Rimantadine Aminotetralins: 5-OH-DPAT 7-OH-DPAT 8-OH-PBZI Rotigotine UH-232 Ergolines: Bromocriptine Cabergoline...
28 KB (2,386 words) - 21:26, 25 July 2024
neurotransmitter glutamate or the binding to its receptors. These include riluzole, memantine, gabapentin, N-acetylcysteine (NAC), topiramate, and lamotrigine. Research...
169 KB (18,655 words) - 20:40, 2 November 2024
v t e Stimulants Adamantanes Adapromine Amantadine Bromantane Memantine Rimantadine Adenosine antagonists 8-Chlorotheophylline 8-Cyclopentyltheophylline...
35 KB (2,928 words) - 09:06, 12 November 2024
amantadine (1-aminoadamantane), rimantadine (1-(1-aminoethyl)adamantane), and memantine (1-amino-3,5-dimethyladamantane) that is marketed in Russia for the treatment...
9 KB (847 words) - 02:07, 8 October 2024
Ifenprodil Igmesine (JO-1784) IPAB Ketamine L-687384 MDMA (midomafetamine) Memantine Methamphetamine Methoxetamine Methylphenidate Nepinalone Neuropeptide...
58 KB (5,400 words) - 22:57, 21 November 2024
v t e Stimulants Adamantanes Adapromine Amantadine Bromantane Memantine Rimantadine Adenosine antagonists 8-Chlorotheophylline 8-Cyclopentyltheophylline...
126 KB (12,440 words) - 14:30, 20 November 2024